Ambu A/S (OTCMKTS:AMBBY) Announces Quarterly Earnings Results

Ambu A/S (OTCMKTS:AMBBY) announced its quarterly earnings data on Thursday. The company reported $0.10 earnings per share (EPS) for the quarter, Zacks reports. Ambu A/S had a net margin of 4.30% and a return on equity of 4.11%.

Ambu A/S Price Performance

Shares of AMBBY remained flat at $19.01 during mid-day trading on Thursday. The stock has a 50-day simple moving average of $15.81 and a 200 day simple moving average of $18.09. Ambu A/S has a 12 month low of $13.02 and a 12 month high of $22.65. The stock has a market cap of $4.47 billion and a PE ratio of 158.38. The company has a current ratio of 2.49, a quick ratio of 1.47 and a debt-to-equity ratio of 0.09.

Ambu A/S Dividend Announcement

The firm also recently declared a dividend, which was paid on Monday, December 23rd. Shareholders of record on Friday, December 6th were paid a dividend of $0.0557 per share. The ex-dividend date of this dividend was Friday, December 6th. Ambu A/S’s dividend payout ratio is 25.00%.

Ambu A/S Company Profile

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.